Global Microfluidics Market Overview:
Global Microfluidics Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2026-2035, Considering the Base Year As 2025.
Global Microfluidics Market Report 2026 comes with the extensive industry analysis with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Microfluidics involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Microfluidics Market:
The Microfluidics Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Microfluidics Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Microfluidics Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Microfluidics market has been segmented into:
Devices
Components
By Application, Microfluidics market has been segmented into:
In-Vitro Diagnostics
Pharmaceutical & Life Science Research and Manufacturing
Therapeutics).
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Microfluidics market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Microfluidics market.
Top Key Players Covered in Microfluidics market are:
Abbott Laboratories
Agilent Technologies Inc.
Becton
Dickinson and Company
bioMerieux SA
Bio-Rad Laboratories Inc.
Cellix Biosciences Inc
Danaher Corporation
Dolomite Microfluidics
Elveflow
F. Hoffmann-La Roche AG
Fluidigm Corporation
Illumina Inc.
Microfluidic ChipShop GmbH
Micronit Microtechnologies
PerkinElmer Inc.
Qiagen NV
Thermo Fisher Scientific Inc.
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Microfluidics Market Type
4.1 Microfluidics Market Snapshot and Growth Engine
4.2 Microfluidics Market Overview
4.3 Devices
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Devices: Geographic Segmentation Analysis
4.4 Components
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.4.3 Components: Geographic Segmentation Analysis
Chapter 5: Microfluidics Market Application
5.1 Microfluidics Market Snapshot and Growth Engine
5.2 Microfluidics Market Overview
5.3 In-Vitro Diagnostics
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 In-Vitro Diagnostics: Geographic Segmentation Analysis
5.4 Pharmaceutical & Life Science Research and Manufacturing
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.4.3 Pharmaceutical & Life Science Research and Manufacturing: Geographic Segmentation Analysis
5.5 Therapeutics).
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.5.3 Therapeutics).: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Microfluidics Market Share by Manufacturer (2025)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 ABBOTT LABORATORIES; AGILENT TECHNOLOGIES
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 INC.; BECTON
6.4 DICKINSON AND COMPANY; BIOMERIEUX SA; BIO-RAD LABORATORIES
6.5 INC.; CELLIX BIOSCIENCES INC
6.6 ; DANAHER CORPORATION; DOLOMITE MICROFLUIDICS; ELVEFLOW; F. HOFFMANN-LA ROCHE AG; FLUIDIGM CORPORATION; ILLUMINA
6.7 INC.; MICROFLUIDIC CHIPSHOP GMBH; MICRONIT MICROTECHNOLOGIES; PERKINELMER
6.8 INC.; QIAGEN NV; THERMO FISHER SCIENTIFIC
6.9 INC.
Chapter 7: Global Microfluidics Market By Region
7.1 Overview
7.2. North America Microfluidics Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Devices
7.2.2.2 Components
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 In-Vitro Diagnostics
7.2.3.2 Pharmaceutical & Life Science Research and Manufacturing
7.2.3.3 Therapeutics).
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Microfluidics Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Devices
7.3.2.2 Components
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 In-Vitro Diagnostics
7.3.3.2 Pharmaceutical & Life Science Research and Manufacturing
7.3.3.3 Therapeutics).
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Microfluidics Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Devices
7.4.2.2 Components
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 In-Vitro Diagnostics
7.4.3.2 Pharmaceutical & Life Science Research and Manufacturing
7.4.3.3 Therapeutics).
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Microfluidics Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Devices
7.5.2.2 Components
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 In-Vitro Diagnostics
7.5.3.2 Pharmaceutical & Life Science Research and Manufacturing
7.5.3.3 Therapeutics).
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Microfluidics Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Devices
7.6.2.2 Components
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 In-Vitro Diagnostics
7.6.3.2 Pharmaceutical & Life Science Research and Manufacturing
7.6.3.3 Therapeutics).
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Microfluidics Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Devices
7.7.2.2 Components
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 In-Vitro Diagnostics
7.7.3.2 Pharmaceutical & Life Science Research and Manufacturing
7.7.3.3 Therapeutics).
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Microfluidics Scope:
|
Report Data
|
Microfluidics Market
|
|
Microfluidics Market Size in 2025
|
USD XX million
|
|
Microfluidics CAGR 2025 - 2032
|
XX%
|
|
Microfluidics Base Year
|
2024
|
|
Microfluidics Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Abbott Laboratories, Agilent Technologies Inc., Becton, Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories Inc., Cellix Biosciences Inc,, Danaher Corporation, Dolomite Microfluidics, Elveflow, F. Hoffmann-La Roche AG, Fluidigm Corporation, Illumina Inc., Microfluidic ChipShop GmbH, Micronit Microtechnologies, PerkinElmer Inc., Qiagen NV, Thermo Fisher Scientific Inc..
|
|
Key Segments
|
By Type
Devices
Components
By Applications
In-Vitro Diagnostics
Pharmaceutical & Life Science Research and Manufacturing
Therapeutics).
|
